ArteraAI Breast

by Artera  · Based in United States → — Accessible Precision Medicine
Oncology Pathology

Contact for pricing
Regulatory Status Disclosed

Overview

ArteraAI Breast is an AI-powered, digital pathology-based risk stratification tool for patients with early-stage, hormone receptor-positive (HR+), HER2-negative invasive breast cancer. It utilizes multimodal artificial intelligence (MMAI) to analyze digitized histopathology images from breast resection specimens and physician-provided clinical variables (age, tumor size, and nodal status) to generate a personalized risk score. This score estimates a patient’s 5- and 10-year likelihood of developing distant metastasis and stratifies them into low- or high-risk groups. The tool is designed to assist physicians in making prognostic risk-based decisions and to help determine the intensity of treatment, potentially guiding chemotherapy decisions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered risk stratification for early-stage breast cancer
  • Utilizes digitized histopathology images and clinical variables
  • Provides 5- and 10-year risks of distant metastasis
  • Stratifies patients into low- and high-risk groups
  • Aids in prognostic risk-based treatment decisions
  • Potential to guide chemotherapy benefit decisions
  • Fast, convenient, and non-tissue consumptive
  • Software-only device
  • CE Marked under EU IVDR
  • Integrates with existing pathology workflows

Use Cases

  • Assessing the likelihood of distant metastasis in HR+/HER2- early-stage breast cancer patients
  • Personalizing treatment decisions for breast cancer patients
  • Guiding the intensity of adjuvant therapy, including chemotherapy
  • Providing prognostic insights to support discussions about prognosis and treatment planning
  • Risk stratification at the point of diagnosis
  • Integrating AI into pathology workflows for enhanced decision support

Details

Category Clinical Decision Support & Reference, Oncology AI, Pathology AI
Pricing Contact for pricing
DeploymentCloud-based (software only)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Pathology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2026-05-04K254115 510(k)ArteraAI Breast

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ArteraAI Breast

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for ArteraAI Breast.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

More from Artera

Artera (formerly WELL Health)
Artera
Patient Engagement & Education
Artera (formerly WELL Health) provides a unified communication hub for health systems, sitting on top of existing EHR systems to automate workflows, send appointment reminders, and collect patient feedback. The platform aims to deliver the best experience to patients and healthcare staff through seamless, integrated communications, allowing patients to manage healthcare communications from one recognizable phone number and staff to reduce busy work.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-11-19

Investors who backed ArteraAI Breast

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.